Immatics (IMTX) EBIT Margin Growth (3y) (2022 - 2025)
Immatics (IMTX) EBIT Margin Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 7,794.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - | -15,758.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15,758.00 |
| Sep 30, 2025 | -84,434.00 |
| Jun 30, 2025 | -191,010.00 |
| Mar 31, 2025 | -37,376.00 |
| Dec 31, 2024 | 18,847.00 |
| Sep 30, 2024 | 39,531.00 |
| Jun 30, 2024 | 42,666.00 |
| Mar 31, 2024 | 31,677.00 |
| Dec 31, 2023 | 7,359.00 |
| Sep 30, 2023 | 169,480.00 |
| Jun 30, 2023 | 22,542.00 |
| Mar 31, 2023 | -11,512.00 |
| Dec 31, 2022 | 31,793.00 |
| Sep 30, 2022 | -3,857.00 |
| Jun 30, 2022 | 5,605.00 |